比較リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：幹細胞研究の世界市場
市場調査レポート
商品コード
243086

幹細胞研究の世界市場

Stem Cells
出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 162 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.65円

ご注意：Single user licenseはDRM（デジタル著作権管理システム）付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

幹細胞研究の世界市場
出版日: 2021年04月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 162 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、幹細胞研究の世界市場を分析し、米国/欧州/その他の地域についての包括的な地域別分析を提供し、2008-2017年間の年間業績を推定/予測するとともに、主要/ニッチプレーヤ87社の企業プロファイルを盛り込み、概略下記の構成でお届けいたします。

第1章　イントロダクション、方法論、製品定義

第2章　エグゼクティブサマリ

第3章　市場概要

  • 概要
  • これまでの主要な成果
  • 幹細胞研究における大きな歴史的出来事
  • 新たな成長分野
  • 整形外科用製品：有望な成長部門
  • 臍帯血幹細胞の実用的機能
  • 課題
  • 幹細胞研究と倫理的角度

第4章　市場の動態とトレンド

  • 北米が世界の幹細胞市場を支配
  • 医療分野を再形成する幹細胞の躍進
  • 世界初の体性幹細胞ベースの治療を公開する韓国
  • 新技術への甚大な関心
  • 倫理的問題と発生期状態：幹細胞の主要市場阻害要因
  • 幹細胞治療における医療ツアーの上昇
  • 幹細胞治療の医療ツアーを防止せずにいる政府規制
  • 幹細胞特許において欧州に大きく差をつける米国と日本

第5章　幹細胞市場の動態：タイプ別

  • 成人体幹細胞が握る多大な可能性
  • 成体幹細胞と胚性幹細胞：比較
  • ロー・リスクの投資
  • 成体幹細胞の方が多くの研究用投資を集める
  • 汎用性の低さ：成体幹細胞の主な制限要因
  • 造血幹細胞：持続的な成功に沸く
  • 阻害要因
  • 間充織幹細胞：有望な治療的オプション
  • 隔離性の難しさと理解度の低さが成長を阻害
  • 人工多能性幹細胞：ESCの代替
  • iPS発見の概要
  • 医薬品開発：iPSの主要アプリケーション
  • 再生医療
  • iPS細胞バンクの構築
  • 難病/先天性疾患の治療
  • 臓器治療
  • 医療分野を一変させる胚性幹細胞
  • 安全性と有効性のデータ不足が引き続き問題

第6章　アプリケーション別幹細胞研究

  • 疾病管理における幹細胞
  • 再生医療における幹細胞治療
  • 幹細胞治療：神経障害に対する有望な治療
  • 大規模な研究に要求される心臓血管系疾患における早期的成果の立証
  • 癌の幹細胞治療
  • 個人医療に足を踏み入れる幹細胞
  • 高齢化人口が促進する整形外科向け幹細胞市場
  • その他の疾患
  • ドラッグデリバリーにおける幹細胞
  • 医薬品開発用ツール

第7章　規制環境

  • 幹細胞研究を支配する法律：分断された世界
  • 主要国における幹細胞研究の法律と規制

第8章　製品概要

  • 幹細胞研究
  • 幹細胞：解説
  • 幹細胞のタイプ
  • 胚性幹細胞
  • 成体幹細胞
  • その他の主要細胞タイプ
  • 幹細胞：特性
  • 自然に再生する能力
  • 可能性
  • 多様な潜在力の定義
  • 幹細胞の識別
  • 幹細胞：アプリケーション
  • 幹細胞の歴史
  • 幹細胞：サービスと製品
  • 幹細胞製品/サービスの重大性

第9章　研究の飛躍的発見

第10章　製品紹介/革新

第11章　最近の業界活動

第12章　戦略的企業発展：歴史的展望材料

第13章　世界の主要プレーヤへの焦点

第14章　世界市場展望

  • 米国
  • 欧州
  • その他の地域
目次
Product Code: MCP-6142

Abstract:

Global Stem Cells Market to Reach $15.1 Billion by 2027

Amid the COVID-19 crisis, the global market for Stem Cells estimated at US$9.1 Billion in the year 2020, is projected to reach a revised size of US$15.1 Billion by 2027, growing at aCAGR of 7.4% over the period 2020-2027. Adult Stem Cells, one of the segments analyzed in the report, is projected to record 7.2% CAGR and reach US$12.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Other Product Types segment is readjusted to a revised 8.5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $2.7 Billion, While China is Forecast to Grow at 6.9% CAGR

The Stem Cells market in the U.S. is estimated at US$2.7 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.6 Billion by the year 2027 trailing a CAGR of 6.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.9% and 6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6% CAGR.

Select Competitors (Total 66 Featured) -

  • apceth Biopharma GmbH
  • Athersys Inc.
  • AVIVA BioSciences Corporation
  • BioE Inc.
  • Bone Therapeutics SA
  • Cesca Therapeutics Inc.
  • Cryo-Cell International Inc.
  • Cytori Therapeutics Inc.
  • ESI BIO
  • Gamida Cell Ltd.
  • Holostem Terapie Avanzate
  • International Stem Cell Corp.
  • Kangstem Biotech. Ltd.
  • Lonza Group Ltd.
  • Mesoblast Ltd.
  • Neuralstem Inc.
  • Nuvasive Inc.
  • OncoMed Pharmaceuticals Inc.
  • Osiris Therapeutics Inc.
  • Promethera Biosciences S.A.N.V
  • Reliance Life Sciences
  • ReNeuron Group Plc.
  • Stemcell Technologies Inc.
  • Stemedica Cell Technologies Inc.
  • Stempeutics Research Pvt. Ltd.
  • Takara Bio USA Inc.
  • TiGenix NV
  • U.S Stem Cell Inc.
  • ViaCord

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Stem Cells - Offering Potential for Breakthrough Therapeutic Discoveries
    • Recent Market Activity
    • Select Approved Stem Cell Products
    • Stem Cells Bypass Use of Animal Models in Drug Discovery Programs
    • Trends Related to Stem Cell Clinical Trials
    • Select Stem Cell Pipeline Analysis
    • Current & Future Analysis
    • Stem Cell Research Funding Policies across the World
    • Japan and US - Pioneering Induced Pluripotent Stem Cell (iPSC) Research
    • Adult Stem Cells Deemed More Ethical, More Research Needed to Increase Clinical Applications
    • Dental Mesenchymal Stem Cells - Emergence of a Niche Market
    • For-Profit, Unregulated Clinics: The Flipside of Stem Cell Research
    • Unproven Therapies Do Online Rounds as Effective Treatment Options - A Cause of Concern
  • 2. FOCUS ON SELECT PLAYERS
    • Athersys, Inc. (USA)
    • Apceth GmbH & Co.KG (Germany)
    • AVIVA BioSciences Corporation (USA)
    • BioE, Inc. (USA)
    • Bone Therapeutics SA (Belgium)
    • Cesca Therapeutics, Inc. (USA)
    • Cryo-Cell International, Inc. (USA)
    • Cytori Therapeutics, Inc. (USA)
    • ESI BIO, a Division of BioTime Inc. (USA)
    • Gamida Cell Ltd. (Israel)
    • Holostem Terapie Avanzate (Italy)
    • International Stem Cell Corporation (USA)
    • Kangstem Biotech., Ltd. (Korea)
    • Lonza Group Ltd (Switzerland)
    • Mesoblast Ltd. (Australia)
    • Neuralstem, Inc. (USA)
    • Nuvasive, Inc. (USA)
    • Osiris Therapeutics, Inc. (USA)
    • OncoMed Pharmaceuticals, Inc (USA)
    • PROMETHERA Biosciences S.A.N.V (Belgium)
    • Reliance Life Sciences (India)
    • ReNeuron Group Plc. (UK)
    • STEMCELL Technologies, Inc. (Canada)
    • Stemedica Cell Technologies, Inc (USA)
    • Stempeutics Research Pvt. Ltd. (India)
    • Takara Bio USA Inc (USA)
    • TiGenix NV (Belgium)
    • U.S Stem Cell, Inc. (USA)
    • ViaCord, LLC (USA)
  • 3. MARKET TRENDS & DRIVERS
    • Researchers at UCLA Successfully Develop 3D Lung Organoids using Stem Cells
    • Embryonic Stem Cell Gene Nanog Found to Reverse Aging
    • Canadian and Dutch Scientists Finds the "Genetic Switch" to Increase Stem Cell Volume from Cord Blood
    • The Boston Program Pioneers Cell-based Personalized Diabetes Treatment
    • iPSCs Provide Valuable Source for Retinal Transplants and Other Applications
    • Albumin-Free Culture of Pluripotent Stem Cells Enables Application in Cardiac Disorders
    • Stem Cell Therapy - An Alternative to Orthopedic Surgery in Younger Patients?
    • Application of Plant Stem Cells in Cosmetic Treatments - Myths Busted
    • Adverse Reactions of Stem Cell-Face Lift Therapy
    • Stem Cell-Breast Enhancement
    • Other Innovations Using Stem Cells
    • New Stem Cell Software & Products
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 2: World 7-Year Perspective for Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
    • TABLE 3: World Current & Future Analysis for Adult Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 4: World 7-Year Perspective for Adult Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 5: World Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 6: World 7-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 8: World 7-Year Perspective for Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 9: World Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 10: World 7-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 11: USA Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 12: USA 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027
    • TABLE 13: USA Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 14: USA 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027
  • CANADA
    • TABLE 15: Canada Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 16: Canada 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027
    • TABLE 17: Canada Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 18: Canada 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027
  • JAPAN
    • TABLE 19: Japan Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 20: Japan 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027
    • TABLE 21: Japan Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 22: Japan 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027
  • CHINA
    • TABLE 23: China Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 24: China 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027
    • TABLE 25: China Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 26: China 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027
  • EUROPE
    • TABLE 27: Europe Current & Future Analysis for Stem Cells by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 28: Europe 7-Year Perspective for Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
    • TABLE 29: Europe Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 30: Europe 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027
    • TABLE 31: Europe Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 32: Europe 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027
  • FRANCE
    • TABLE 33: France Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 34: France 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027
    • TABLE 35: France Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 36: France 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027
  • GERMANY
    • TABLE 37: Germany Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Germany 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027
    • TABLE 39: Germany Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 40: Germany 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027
  • ITALY
    • TABLE 41: Italy Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 42: Italy 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027
    • TABLE 43: Italy Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Italy 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027
  • UNITED KINGDOM
    • TABLE 45: UK Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 46: UK 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027
    • TABLE 47: UK Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 48: UK 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027
  • REST OF EUROPE
    • TABLE 49: Rest of Europe Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 50: Rest of Europe 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027
    • TABLE 51: Rest of Europe Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 52: Rest of Europe 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 53: Asia-Pacific Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 54: Asia-Pacific 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027
    • TABLE 55: Asia-Pacific Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Asia-Pacific 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027
  • REST OF WORLD
    • TABLE 57: Rest of World Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 58: Rest of World 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027
    • TABLE 59: Rest of World Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 60: Rest of World 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 66